Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials

BACKGROUND: Outcomes for patients in the second-line setting of advanced urothelial carcinoma (UC) are dismal. The recognized prognostic factors in this context are Eastern Cooperative Oncology Group (ECOG) performance status (PS) >0, hemoglobin level (Hb) <10 g/dl, and liver metastasis (LM)....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sonpavde, Guru, Pond, Gregory R., Fougeray, Ronan, Choueiri, Toni K., Qu, Angela Q., Vaughn, David J., Niegisch, Guenter, Albers, Peter, James, Nicholas D., Wong, Yu-Ning, Ko, Yoo-Joung, Sridhar, Srikala S., Galsky, Matthew D., Petrylak, Daniel P., Vaishampayan, Ulka N., Khan, Awais, Vogelzang, Nicholas J., Beer, Tomasz M., Stadler, Walter M., O’Donnell, Peter H., Sternberg, Cora N., Rosenberg, Jonathan E., Bellmunt, Joaquim
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4127896/
https://ncbi.nlm.nih.gov/pubmed/23206856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2012.11.042
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados